[1]李安诺,岳仁宋.基于CiteSpace的糖尿病合并血脂异常的知识图谱可视化分析[J].医学信息,2023,36(16):40-46.[doi:10.3969/j.issn.1006-1959.2023.16.007]
　LI An-nuo,YUE Ren-song.Visualization Analysis on Knowledge Map of Diabetes Mellitus Complicated with Dyslipidemia Based on CiteSpace[J].Journal of Medical Information,2023,36(16):40-46.[doi:10.3969/j.issn.1006-1959.2023.16.007]
点击复制

基于CiteSpace的糖尿病合并血脂异常的知识图谱可视化分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年16期
页码:
40-46
栏目:
医学数据科学
出版日期:
2023-08-15

文章信息/Info

Title:
Visualization Analysis on Knowledge Map of Diabetes Mellitus Complicated with Dyslipidemia Based on CiteSpace
文章编号:
1006-1959（2023）16-0040-07
作者:
李安诺; 岳仁宋
（成都中医药大学附属医院内分泌科，四川 成都 610072）
Author(s):
LI An-nuo; YUE Ren-song
(Department of Endocrinology,Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,Sichuan,China)
关键词:
CiteSpace; 糖尿病合并血脂异常; 高脂血症; 糖尿病
Keywords:
CiteSpace; Diabetes mellitus complicated with dyslipidemia; Dyslipidemia; Diabetes mellitus
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2023.16.007
文献标志码:
A
摘要:
目的 分析国内糖尿病合并血脂异常研究热点及现状，探索未来发展方向。方法 以CNKI中文数据库作为资料来源，检索自建库以来至2021年12月31日的糖尿病合并血脂异常相关高质量文献，将数据导入CiteSpace软件进行可视化分析，通过合作网络、关键词聚类、关键词共现等分析作者、机构、时间线、研究热点及未来趋势。结果 共检索到1362篇相关文献，筛选后共纳入232篇。该领域研究已开展30余年，发文量呈现先上升后逐渐下降的趋势；作者可视化后得到韩淑英、徐向进为最高产作者；机构可视化分析显示华北煤炭医学院药理学教研室出现频次最多；关键词共计238个，排名前5的为高脂血症、糖尿病、血脂、血糖、血脂康；关键词聚类分析获得11个有代表性的聚类，大致可分为治疗药物、临床研究、机制研究3类；突现词显示依折麦布在近年受到最多关注。结论 目前国内糖尿病合并血脂异常领域还有较大的研究空间及研究必要性，该领域目前还未形成联系紧密的作者团体，研究深度不足。随着研究的进一步深入，还需进一步加强多机构、多学科间的合作；聚焦国际前沿、开展更多高质量研究；发挥中医药优势、重视中医药研究现代化，以推动该领域发展和进步，以更好解决临床问题。
Abstract:
Objective To analyze the research hotspots and current situation of diabetes mellitus complicated with dyslipidemia in China, and to explore the future development direction.Methods Taking CNKI Chinese database as the data source, the high-quality literatures related to diabetes mellitus complicated with dyslipidemia from the establishment of the database to December 31, 2021 were retrieved, and the data were imported into CiteSpace software for visual analysis. The authors, institutions, time lines, research hotspots and future trends were analyzed through cooperation network, keyword clustering and keyword co-occurrence.Results A total of 1362 relevant articles were searched, and 232 articles were included after being filtered. In the past 30 years, the total number of papers published in the field showed a trend of increasing first and then gradually decreasing. After the author visualized, Han Shuying and Xu Xiangjin were the highest-yield authors; the visual analysis of institutions showed that the Department of Pharmacology of North China Coal Medical University had the highest frequency of occurrence. There were 238 keywords in total, and the top 5 were hyperlipidemia, diabetes, blood lipids, blood glucose, and Xuezhikang. Eleven representative clusters were obtained by keyword clustering analysis, which could be roughly divided into three categories: therapeutic drugs, clinical research and mechanism research. Burst terms showed that ezetimibe had received the most attention in recent years.Conclusion At present, there is still a large research space and research necessity in the field of diabetes mellitus complicated with dyslipidemia in China. And there is no closely related author group in this field, as well as the research depth is insufficient. With the further deepening of research, it is necessary to further strengthen multi-agency and multi-disciplinary cooperation; focus on the international frontier and carry out more high-quality research; give full play to the advantages of traditional Chinese medicine and attach importance to the modernization of traditional Chinese medicine research, so as to promote the development and progress of this field and better solve clinical problems.

参考文献/References:

[1]Sun H,Saeedi P,Karuranga S,et al.IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J].Diabetes Res Clin Pract,2022,183:109119.[2]朱婧,蒋晓红,项守奎,等.1型糖尿病患者尿酸水平与血脂异常的相关性研究[J].国际内分泌代谢杂志,2020,40(1):16-20.[3]中华医学会内分泌学分会脂代谢学组.中国2型糖尿病合并血脂异常防治专家共识(2017年修订版)[J].中华内分泌代谢杂志,2017,33(11):925-936.[4]American Diabetes Association.10.Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2020[J].Diabetes Care,2020,43(Suppl 1):S111-S134.[5]Chen C.Searching for intellectual turning points: progressive knowledge domain visualization[J].Proc Natl Acad Sci U S A,2004,101 Suppl 1(Suppl 1):5303-5310.[6]陈悦,陈超美,刘则渊,等.CiteSpace知识图谱的方法论功能[J].科学学研究,2015,33(2):242-253.[7]宋秀芳,迟培娟.Vosviewer与Citespace应用比较研究[J].情报科学,2016,34(7):108-112,146.[8]胡利勇.基于普赖斯定律的图书情报领域高被引论文核心要素测评[J].图书馆研究,2016,46(4):113-117.[9]李田,魏亚威,马利.基于CiteSpace的我国中医“治未病”文献知识图谱分析[J].中国中医基础医学杂志,2018,24(11):1526-1529.[10]郑寿焕,李金姬,张春子,等.CD36基因多态性对2型糖尿病患者血脂和CRP的影响[J].山东医药,2011,51(17):4-6.[11]多力坤·买买提玉素甫,祖克拉·肉孜,宋曼殳,等.PPARG基因taqSNPs遗传模型及单体型与2型糖尿病的相关性[J].新疆大学学报(自然科学版),2015,32(4):399-409,505.[12]马尧,姜维娜,江红.2型糖尿病伴高脂血症患者氧化应激反应与血脂代谢紊乱的关系研究[J].临床和实验医学杂志,2017,16(11):1102-1104.[13]Fan D,Li L,Li Z,et al.Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes[J].Lipids Health Dis,2018,17(1):102.[14]鞠礼,张明宇.血脂代谢紊乱对2型糖尿病患者氧化应激反应的影响[J].哈尔滨医科大学学报,2014,48(3):215-217.[15]葛进,郑喜兰,雒瑢,等.替米沙坦对高脂喂养大鼠血清NO及iNOS的影响[J].天津医药,2011,39(6):561-562.[16]解合兰.脂泰胶囊对T2DM患者NO、ET及CRP的影响[J].山东医药,2006,46(7):34-35.[17]景怡,景荣琴,胡天惠.玉米须总黄酮对糖尿病高脂血症大鼠血脂、血糖水平的影响及抗氧化作用[J].中药药理与临床,2011,27(2):85-86.[18]江正菊,宁林玲,胡霞敏,等.桑叶总黄酮对高脂诱导大鼠高血脂及高血糖的影响[J].中药材,2011,34(1):108-111.[19]刘晓丽,韩峰,姜彩霞,等.调脂治疗对初诊2型糖尿病患者血糖的影响[J].中国糖尿病杂志,2010,18(2):129-131.[20]潘文杰,陈良苗,孙维文,等.降糖联合他汀降脂疗法对混合型血脂异常的2型糖尿病患者血脂的影响[J].中国药房,2015,26(32):4557-4559.[21]孙晔子,沈莉敏,孙欢欢,等.瑞舒伐他汀联合非诺贝特治疗2型糖尿病合并高脂血症的疗效观察[J].河北医学,2017,23(9):1419-1423.[22]毛月芹,刘晔,苏建华.依折麦布联合瑞舒伐他汀治疗2型糖尿病合并高脂血症患者的临床研究[J].中国临床药理学杂志,2021,37(20):2741-2744.[23]张玉泉,杨建锋.消渴丸联合血脂康对2型糖尿病高脂血症MBL的影响[J].中国实验方剂学杂志,2013,19(8):274-277.[24]肖燕倩,郭美珠,唐素芬,等.参脂灵合血脂康治疗2型糖尿病高脂血症的临床研究[J].上海中医药杂志,2004,38(12):11-13.[25]毛月芹,刘晔,苏建华.依折麦布联合瑞舒伐他汀治疗2型糖尿病合并高脂血症患者的临床研究[J].中国临床药理学杂志,2021,37(20):2741-2744.[26]李建军,石文娜.依折麦布联合非诺贝特治疗混合型高脂血症及颈动脉斑块的临床疗效及安全性[J].中国老年学杂志,2020,40(4):720-722.[27]中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会. 糖尿病合并高脂血症病证结合诊疗指南[J].世界中医药,2021,16(16):2377-2385. [28]朱伟宏,黄柯柯.不同剂量血脂康联合依折麦布对2型糖尿病合并高脂血症患者疗效分析[J].中国循证心血管医学杂志,2016,8(10):1234-1236.[29]张世卿,金晓艳,胡晨,等.降糖胶囊对实验性Ⅱ型糖尿病大鼠胰岛素抵抗的改善作用[J].中药药理与临床,2010,26(5):135-136.[30]陈利平,刘梅.大柴胡汤化裁方治疗2型糖尿病合并高脂血症58例疗效观察[J].新中医,2005,37(11):34-35.[31]叶一萍,丁晓媚,王法明,等.马齿苋治疗糖尿病合并高脂血症的临床疗效观察[J].中华中医药学刊,2015,33(6):1398-1400.[32]范冠杰,彭颖华.针药合用对非胰岛素依赖型糖尿病患者血脂影响的临床研究[J].中国针灸,1998(3):11-13.[33]王敬浩,黄叔怀.太极拳运动对高脂血症合并Ⅱ型糖尿病患者的疗效观察及其机理探讨[J].体育与科学,2001,22(1):61-64.

相似文献/References:

[1]夏能能,任 薇,杜建平,等.1953~2016年中医药治疗高血压领域研究热点分析[J].医学信息,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
　XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Journal of Medical Information,2018,31(16):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[2]林夏妃,吴海霞,随燕芳,等.2009~2018年癌症康复研究的CiteSpace科学知识图谱可视化分析[J].医学信息,2020,33(02):1.[doi:10.3969/j.issn.1006-1959.2020.02.001]
　LIN Xia-fei,WU Hai-xia,SUI Yan-fang,et al.Visual Analysis of CiteSpace Scientific Knowledge Map for Cancer Rehabilitation Research from 2009 to 2018[J].Journal of Medical Information,2020,33(16):1.[doi:10.3969/j.issn.1006-1959.2020.02.001]
[3]王 瑞,原志芳,沈悦好,等.基于CiteSpace的国内呼吸系统护理研究热点与前沿的可视化分析[J].医学信息,2020,33(10):1.[doi:10.3969/j.issn.1006-1959.2020.10.001]
　WANG Rui,YUAN Zhi-fang,SHEN Yue-hao,et al.Visual Analysis of Hotspots and Frontiers of Domestic Respiratory System Nursing Research Based on CiteSpace[J].Journal of Medical Information,2020,33(16):1.[doi:10.3969/j.issn.1006-1959.2020.10.001]
[4]张士成,王 雪,刘君涵,等.基于文献计量与CiteSpace的国内叙事医学研究热点与进展趋势分析[J].医学信息,2022,35(21):9.[doi:10.3969/j.issn.1006-1959.2022.21.003]
　ZHANG Shi-cheng,WANG Xue,LIU Jun-han,et al.Analysis of Research Hotspots and Progress Trends of Domestic Narrative Medicine Based on Bibliometrics and CiteSpace[J].Journal of Medical Information,2022,35(16):9.[doi:10.3969/j.issn.1006-1959.2022.21.003]
[5]徐鋆娴,谢晓云.基于CiteSpace的老年糖尿病护理研究的可视化分析[J].医学信息,2020,33(23):1.[doi:10.3969/j.issn.1006-1959.2020.23.001]
　XU Jun-xian,XIE Xiao-yun.Visualization Analysis of Elderly Diabetes Nursing Research Based on CiteSpace[J].Journal of Medical Information,2020,33(16):1.[doi:10.3969/j.issn.1006-1959.2020.23.001]
[6]陆柔凤,葛 微.鼻咽癌影响因素研究热点与前沿分析[J].医学信息,2022,35(22):34.[doi:10.3969/j.issn.1006-1959.2022.22.006]
　LU Rou-feng,GE Wei.Research Focus and Frontier Analysis of Influencing Factors of Nasopharyngeal Carcinoma[J].Journal of Medical Information,2022,35(16):34.[doi:10.3969/j.issn.1006-1959.2022.22.006]
[7]徐安迎,魏海斌,陈丽蓉,等.基于CiteSpace的我国医德医风建设研究热点与演化趋势的可视化计量分析[J].医学信息,2021,34(06):20.[doi:10.3969/j.issn.1006-1959.2021.06.006]
　XU An-ying,WEI Hai-bin,CHEN Li-rong,et al.Visual Metrological Analysis of Research Hotspots and Evolutionary Trends of China’s Medical Ethics and Style Construction Based on CiteSpace[J].Journal of Medical Information,2021,34(16):20.[doi:10.3969/j.issn.1006-1959.2021.06.006]
[8]翁梦晴,韦彩萍,任文宁,等.基于CiteSpace的人乳头瘤病毒疫苗可视化分析[J].医学信息,2023,36(03):39.[doi:10.3969/j.issn.1006-1959.2023.03.009]
　WENG Meng-qing,WEI Cai-ping,REN Wen-ning,et al.Visual Analysis of Human Papillomavirus Vaccine Based on CiteSpace[J].Journal of Medical Information,2023,36(16):39.[doi:10.3969/j.issn.1006-1959.2023.03.009]
[9]刘 萍,张嘉鹏.基于知识图谱的MIMIC电子病历数据集的研究热点和趋势分析[J].医学信息,2023,36(07):67.[doi:10.3969/j.issn.1006-1959.2023.07.012]
　LIU Ping,ZHANG Jia-peng.Research Hotspots and Trend Analysis of MIMIC Electronic Medical Record Data Set Based on Knowledge Graph[J].Journal of Medical Information,2023,36(16):67.[doi:10.3969/j.issn.1006-1959.2023.07.012]
[10]赵雨蕾,余 艳,蒋 蓉,等.2012-2021年我国老年患者营养护理的可视化分析[J].医学信息,2023,36(08):24.[doi:10.3969/j.issn.1006-1959.2023.08.005]
　ZHAO Yu-lei,YU Yan,JIANG Rong,et al.Visual Analysis of Nutritional Nursing for Elderly Patients in China from 2012 to 2021[J].Journal of Medical Information,2023,36(16):24.[doi:10.3969/j.issn.1006-1959.2023.08.005]

更新日期/Last Update: 1900-01-01